Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus

Antiviral Research

Volumn 37, Issue 1, 1998, Pages 37-45

  Takegami, Tsutomu ^a   Simamura, Eriko ^a   Hirai, Kei Ichi ^a   Koyama, Junko ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Furanonaphthoquinone; Japanese encephalitis virus; Replication

Indexed keywords

ANTIVIRUS AGENT; FURANONAPHTHOQUINONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENCEPHALITIS; IMMUNOBLOTTING; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; ENCEPHALITIS VIRUS, JAPANESE; MEMBRANE GLYCOPROTEINS; NAPHTHOQUINONES; PLAQUE ASSAY; RNA HELICASES; RNA, VIRAL; SERINE ENDOPEPTIDASES; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; JAPANESE ENCEPHALITIS VIRUS; ORYCTOLAGUS CUNICULUS; RNA VIRUSES;

EID: 0031975661     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00058-2     Document Type: Article

References (23)

1. Binutu, O., Lajubutu, B., 1994. Antimicrobial potentials of some plant species of the Bignoniaceae family. Afr. J. Med. Sci. 23, 269-273.
2. Brown, T.D., Condreay, D., 1986. Replication of alphaviruses in mosquito cells. In: The Togaviridae and Flaviviridae. Plenum, New York, pp. 171-207.
3. Dolin, R., 1988. Rimantadine and Amantadine in the prophylaxis and therapy of influenza A. In: Clinical Use of Antiviral Drugs. Martinus Nijhoff, Boston, pp. 277-288.
4. Fujimoto, Y., Eguchi, T., Murasaki, C., Ohashi, Y., Kakinuma, K., Talagaki, H., Abe, M., Inazawa, K., Yamazaki, K., Ikekawa, N., Yoshikawa, O., Ikekawa, T., 1991. Studies on the structure and stereochemistry of cytotoxic furanonaphthoquinones from Tabebuia impetiginosa: 5-and 8-hydroxy-2-(1-hydroxyethyl)naphtho[2,3-b]furan-4,9-diones. J. Chem. Soc. Perkin Trans. 1, 2323-2327.
5. Hashimoto, H., Nomoto, A., Watanabe, K., Mori, T., Takezawa, T., Arisawa, C., Takegami, T., Hiramatsu, K., 1988. Molecular cloning and complete nucleotide sequence of the genome of Japanese encephalitis virus Beijin-stain. Virus Genes 1, 305-317.
6. Hayashi, T., Smith, F.T., Lee, K.H., 1987. Antitumor agents 89. Psychorubrin, a new cytotoxic naphthoquinone from Psychotria rubra and its structure-activity relationship. J. Med. Chem. 30, 2005.
7. Hirai, K.-I., Koyama, J., Shimada, H., Simamura, E., 1995. Selective antitumor activities of furanonaphthoquinone derivatives against cultured human tumor cells (Abstract). Proc. Jpn. Cancer Assoc. 55, 602.
8. Igarashi, A., 1993. Flavivirus infections in tropical areas. Virus 43, 67-76.
9. Ikekawa, T., Maruyama, H., Miyano, T., Okura, A., Sawasaki, K., Naito, K., Kawamura, K., Shiratori, K., 1985. Proflamine, a new antitumor agent: preparation, physicochemical properties and antitumor activity. Jpn. J. Cancer Res. 76, 142.
10. Inoue, K., Inoue, H., Chen, C.C., 1981. Quinones and related compounds in higher plants. Part 17. A naphthoquinone and a lignan from the wood of Kigelia pinnata. Phytochem. 227, 2271-2276.
11. Koyama, J., Okatani, T., Tagahara, K., Suzuta, Y., 1987. Synthesis of furanonaphthoquinones from T. cassinoides (Abstract). In: Proceedings of the Japanese-United States Congress on Pharmaceutical. Science, Honolulu December 2-7, pp. S142.
12. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
13. Monath, T.P., Schesinger, S., Schesinger, M., 1986. Pathobiology of the flaviviruses. In: The Togaviridae and Flaviviridae. Plenum, New York, pp. 375-440.
14. Pan, J., Hirai, K.-I., Simamura, E., Koyama, J., Shimada, H. and Kuwabara, S., 1997. Mitochondrial damages by a new antitumor agent furanonaphthoquinone derivative in human cervical cancer HeLa cells. J. Electron Microsc., 46, 181-187.
15. Rao, M.M., Kingston, D.G.I., 1982. Plant anticancer agents. Isolation and structure elucidation of new cyotoxic quinones form. J. Nat. Prod. 45, 600-604.
16. Sakai, A., Kaneko, S., Minouchi, K., Matsushita, E., Kobayashi, K., 1995. Buoyant density of HCV and response to INF therapy (Abstract). In: Proceedings of the 3rd International Meeting on Hepatitis C Virus and Related Viruses. Molecular Virology and Pathogenessis, Gold Coast p. 61.
17. Sakamuro, D., Furukawa, T., Takegami, T., 1995. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J. Virol. 69, 3893-3896.
18. Sumiyoshi, H., Mori, C., Fuke, I., Morita, K., Kuhara, S., Kondou, J., Kikuti, Y., Nagamatsu, H., Igarashi, A., 1987. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161, 497-510.
19. Takegami, T., Hotta, S., 1990. Synthesis and localization of Japanese encephalitis virus RNAs in the infected cells. Microbial. Immunol. 34, 849-857.
20. Takegami, T., Miyamoto, H., Nakamura, H., Yasui, K., 1982. Biological activities of the structural proteins of Japanese encephalitis virus. Acta Virol. 26, 312-320.
21. Takegami, T., Sakamuro, D., Furukawa, T., 1994. Japanese encephalitis virus nonstructural protein NS3 has RNA binding and ATPase activities. Virus Genes 9, 105-112.
22. Xu, K., Takegami, T., 1996. Antiviral activity of suramine: inhibitory effect on Japanese encephalitis virus replication. Jpn. J. Trop. Med. Hyg. 24, 99-105.
23. Zulkarnain, E., Takegami, T., 1993. Localization and functions of Japanese encephalitis virus nonstructural proteins NS3 and NS5 for viral RNA synthesis in the infected cells. Microbiol. Immunol. 37, 239-243.